drugset / Trial / NCT06839664
A Study of HS-20094 in Chinese Adults With Overweight or Obesity
RandomizedParallel-groupDouble-blindTreatment
Summary
The main purpose of this study is to assess the Efficacy and safety of HS-20094 in overweight and obese patients. The study will last up to approximately 52 weeks.
Timeline
- Start
- 2024-11-16
- Primary completion
- 2026-01-04
- Completion
- 2026-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olatorepatide | Protein / enzyme biologic | 5 mg | Subcutaneous |
| Subject | Olatorepatide | Protein / enzyme biologic | 10 mg | Subcutaneous |
| Subject | Olatorepatide | Protein / enzyme biologic | 15 mg | Subcutaneous |